Pharmaceutical Excipients Market

Pharmaceutical Excipients Market by Product (Organic (Oleochemicals, Carbohydrates) Inorganic (Calcium Carbonate), Functionality (Fillers, Binders, Lubricants, Diluents), Formulation (Oral, Parenteral), Application (Stablizers) & Region - Global Forecast to 2028

Report Code: PH 3047 Nov, 2023, by marketsandmarkets.com

The global pharmaceutical excipients market in terms of revenue was estimated to be worth $10.0 billion in 2023 and is poised to reach $13.9 billion by 2028, growing at a CAGR of 6.8% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. This is mainly due to various factors such as growing emphasis on patient-centric formulations, increasing demand for generic drugs and pharmaceutical products, increased R&D Investments for the development of novel excipients and collaborations and partnerships with pharmaceutical companies for customized excipient solutions. However, the growing high investments and development costs along with the growing regulatory stringency are predicted to cause market growth barriers.

Attractive Opportunities in the Pharmaceutical Excipients Market.

Pharmaceutical Excipients Market

To know about the assumptions considered for the study, Request for Free Sample Report

Pharmaceutical Excipients Market

Pharmaceutical Excipients Market Dynamics

Driver: Increasing demand for generic drugs and pharmaceutical products is propelling the demand for pharma excipients

The pharmaceutical excipients market is expected to benefit from the growing demand for generic drugs. Generic drugs are cheaper than branded drugs, and their entry into the market is expected to boost the volume of drugs sold. There is an increase in the number of generic drug approvals as due to patent cliff. Leading pharmaceutical companies with significant operations in the United States, such as Zydus Lifesciences, Torrent Pharma, Aurobindo Pharma, and Ajanta Pharma, are poised to reap substantial benefits from this development. Generic drug manufacturers are constantly looking for ways to reduce costs, and excipients can be a significant cost-saving measure. As a result, there is a growing demand for high-quality, affordable excipients which propels the pharmaceutical excipient market. This is considered a positive indicator of the growth of the pharmaceutical excipients market.

Restraint: High Development Costs associated with Novel excipients

The approval process for new excipients can be long, expensive and complex. It requires high capital investments and can further delay the time to market for new excipients, which can make it more difficult for pharmaceutical companies to justify the investment in developing new products. New excipients must be approved by regulatory agencies such as the FDA before they can be used in drug products. Additionally these excipients must be manufactured in large quantities to meet the needs of the pharmaceutical industry. This process can be lengthy and costly and thus is predicted to restrain the market.

Opportunity: Increasing growth of functional/Multifunctional Pharmaceutical Excipients

Co-processed multifunctional excipients are a class of pharmaceutical excipients that are created by combining two or more excipients together using a physical process, such as mixing, blending, or granulation. This process alters the physical properties of the individual excipients, resulting in a new excipient with enhanced functionality. These excipients offer several advantages over existing single function excipients such as reduced number of excipients in a formulation thus simplifying the manufacturing process, improved performance of the formulation due to superior flowability, compressibility, binding, and disintegrating properties compared to individual excipients and reduced variability in formulation properties by ensuring consistent batch-to-batch performance of pharmaceutical formulations therefore providing lucrative future market growth opportunities.

Challenge: Stringent Regulatory Requirements.

Stringent regulatory requirements are a significant challenge for the pharmaceutical excipients market. Regulatory bodies, such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have implemented strict guidelines for the manufacturing, testing, and use of excipients. These regulations are designed to ensure the safety and efficacy of pharmaceutical products. However, stringent regulatory requirements can also increase the complexity of developing and bringing new excipients to market. This can make it challenging for excipient manufacturers to innovate and keep up with the evolving demands of the pharmaceutical industry. For example, the U.S. FDA's rigorous New Drug Application (NDA) process and the European Medicines Agency's (EMA) regulatory requirements can significantly delay the introduction of innovative excipients.

Pharmaceutical Excipients Market Ecosystem Analysis

Pharmaceutical Excipients Market Ecosystem

The Oral Formulations segment commanded share of the pharmaceutical excipients industry in 2022.

On the basis of formulation, the global pharmaceutical excipients market is segmented into oral formulations (Tablets, Capsules, Liquid formulations and others), topical formulations, parenteral formulations and other formulations. The oral formulations segment dominated the pharmaceutical excipients market during the forecast period. Their wide usage and efficacy against many ailments. are some of the factors driving the market growth.

Lubricants and Glidants is likely to grow at significant CAGR in the pharmaceutical excipients industry during the forecast period

On the basis of functionality, the global pharmaceutical excipients market is segmented into fillers & diluents, suspending & viscosity agents, coating agents, binders, flavoring agents & sweeteners, disintegrants, colorants, lubricants & glidants, preservatives, emulsifying agents, and other functionalities. The fillers & diluents segment dominated the market share in 2022 and the lubricants and glidants segment is further expected to project the market growth at faster pace both due to their use in oral solid dosage forms which are the most popular dosage forms.

Asia Pacific predicted to exhibit highest CAGR in the pharmaceutical excipients industry during the forecast period of 2023-2028.

There are six main regional segmentations for the pharmaceutical excipients market—North America, Europe, the Asia Pacific, Latin America, Middle East and Africa. In 2022, Europe dominated the market share due to the presence of numerous large production capacity pharmaceutical giants which drive the high excipient consumption rates. The growing emphasis on superior generics, pharmaceutical products, and biosimilars has also increased the demand for novel excipients, which is predicted to drive market growth.

Pharmaceutical Excipients Market by Region

Source: Expert Interviews, Secondary Research, Whitepapers, Journals, Magazines, and MarketsandMarkets Analysis

To know about the assumptions considered for the study, download the pdf brochure

Key players in the Market include Ashland Inc. (US), Roquette Frères (France), Evonik Industries AG (Germany), International Flavors & Fragrances, Inc. (US), BASF SE (Germany), Kerry Group Plc (Ireland), Associated British Foods Plc (UK), Merck KGaA (Germany), Wacker Chemie AG (Germany) and ADM (US).

Scope of the Pharmaceutical Excipients Industry

Report Metric

Details

Market Revenue in 2023

$10.0 billion

Projected Revenue by 2028

$13.9 billion

Revenue Rate

Poised to Grow at a CAGR of 6.8%

Market Driver

Increasing demand for generic drugs and pharmaceutical products is propelling the demand for pharma excipients

Market Opportunity

Increasing growth of functional/Multifunctional Pharmaceutical Excipients

This report categorizes the pharmaceutical excipients market to forecast revenue and analyze trends in each of the following submarkets:

By Product

  • Organic Chemicals
  • Oleochemicals
    • Fatty Alcohols
    • Mineral Stearates
    • Glycerin
    • Other Oleochemicals
  • Carbohydrates
    • Sugars
      • Actual Sugars
      • Sugar Alcohols
      • Artificial Sweetners
    • Cellulose
      • Microcrystalline cellulose
      • Cellulose ethers
      • Carboxymethyl cellulose (CMC) and croscarmellose sodium
      • Cellulose esters
    • Starch
      • Modified Starch
      • Dried Starch
      • Converted Starch
  • Petrochemicals
    • Glycols
    • Povidones
    • Mineral Hydrocarbons
    • Acrylic Polymers
    • Other Petrochemical Excipients
  • Proteins
  • Other Organic Chemicals
  • Inorganic Chemicals
  • Calcium Phosphate
  • Metal Oxides
  • Halites
  • Calcium Carbonate
  • Calcium Sulphate
  • Other Inorganic Chemicals
  • Other Chemicals

By Functionality

  • Fillers & Diluents
  • Suspending & Viscosity Agents
  • Coating Agents
  • Binders
  • Flavoring Agents & Sweeteners
  • Disintegrants
  • Colorants
  • Lubricants & Glidants
  • Preservatives
  • Emulsifying Agents
  • Other Functionalities

By Formulation

  • Oral Formulations
  • Tablets
  • Capsules
    • Hard-gelatin Capsules
    • Soft-gelatin Capsules
  • Liquid Formulations
  • Other Oral Formulations
  • Topical Formulations
  • Parenteral Formulations
  • Other Formulations

By Functionality Application

  • Taste Masking
  • Stablizers
  • Modified-Release
  • Solubility & Bioavailablity Enhancement
  • Others

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East
  • Africa

Recent Developments of Pharmaceutical Excipients Industry

  • In June 2023, Ashland introduced Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant comprising a glidant and lubricant.
  • In October 2023, Lubrizol Life Science Health was awarded the Finished Formulation Award for Apisolex Polymer solubilizing excipient at CPhI Barcelona.
  • In July 2022, DFE Pharma announced the broadening of its Dry Powder Inhalation (DPI) portfolio by launching Lactohale 400.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 44)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 YEARS CONSIDERED
           1.3.3 CURRENCY CONSIDERED
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
           1.5.1 RECESSION IMPACT
 
2 RESEARCH METHODOLOGY (Page No. - 49)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 2 BREAKDOWN OF PRIMARIES
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 3 PHARMACEUTICAL EXCIPIENTS MARKET SIZE ESTIMATION (2022)
          FIGURE 4 APPROACH 1: REVENUE SHARE ANALYSIS
          FIGURE 5 REVENUE SHARE ANALYSIS OF INTERNATIONAL FLAVORS & FRAGRANCES INC.: PHARMACEUTICAL EXCIPIENTS MARKET SHARE (2022)
           2.2.1 PRIMARY INSIGHTS
                    FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
           2.2.2 SEGMENTAL ASSESSMENT: PHARMACEUTICAL EXCIPIENTS MARKET SHARE
                    FIGURE 7 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
    2.3 GROWTH RATE ASSUMPTIONS 
          FIGURE 8 CAGR PROJECTION: PHARMACEUTICAL EXCIPIENTS MARKET SHARE
          FIGURE 9 GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
    2.4 MARKET BREAKDOWN & DATA TRIANGULATION 
          FIGURE 10 DATA TRIANGULATION METHODOLOGY
    2.5 STUDY ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
    2.7 RISK ANALYSIS 
    2.8 RECESSION IMPACT: PHARMACEUTICAL EXCIPIENTS MARKET SHARE 
          TABLE 1 GLOBAL INFLATION RATE PROJECTION, 2021–2028 (% GROWTH)
          TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
          TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
 
3 EXECUTIVE SUMMARY (Page No. - 62)
    FIGURE 11 PHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
    FIGURE 12 PHARMACEUTICAL EXCIPIENTS MARKET FORECAST, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)
    FIGURE 13 PHARMACEUTICAL EXCIPIENTS MARKET FORECAST, BY FORMULATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 14 PHARMACEUTICAL EXCIPIENTS MARKET FORECAST, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028 (USD MILLION)
    FIGURE 15 PHARMACEUTICAL EXCIPIENTS MARKET FORECAST: GEOGRAPHICAL SNAPSHOT
 
4 PREMIUM INSIGHTS (Page No. - 66)
    4.1 PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW 
          FIGURE 16 GROWTH IN GENERICS AND PHARMACEUTICAL PRODUCT DEMAND TO DRIVE MARKET GROWTH
    4.2 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FORECAST 
          FIGURE 17 ORGANIC CHEMICALS HELD LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 PHARMACEUTICAL EXCIPIENTS MARKET TRENDS: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 68)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 19 PHARMACEUTICAL EXCIPIENTS MARKET TRENDS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
          TABLE 4 PHARMACEUTICAL EXCIPIENTS MARKET TRENDS: IMPACT ANALYSIS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing demand for generic drugs and pharmaceutical products
                                TABLE 5 BRAND NAMES AND GENERIC COUNTERPARTS
                    5.2.1.2 Increased R&D investments to develop novel excipients
                                FIGURE 20 GLOBAL PHARMACEUTICAL DRUG SALES (2008–2022)
                    5.2.1.3 Growing emphasis on patient-centric formulations to fuel demand for specialized excipients
                    5.2.1.4 Collaborations and partnerships with pharmaceutical companies for customized excipient solutions
           5.2.2 RESTRAINTS
                    5.2.2.1 Stringent regulatory requirements
                    5.2.2.2 High development costs
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Rising demand for functional/multifunctional pharmaceutical excipients
                                TABLE 6 MULTIFUNCTIONAL EXCIPIENTS
                    5.2.3.2 Advancements in nanotechnology
                    5.2.3.3 Emerging markets in Asia Pacific and Latin America
           5.2.4 CHALLENGES
                    5.2.4.1 Safety and quality concerns
                    5.2.4.2 Limited availability of certain raw materials used in excipient production
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 21 REVENUE SHIFT AND NEW POCKETS FOR PHARMACEUTICAL EXCIPIENT PROVIDERS
    5.4 PRICING ANALYSIS 
          TABLE 7 PRICING ANALYSIS (USD)
    5.5 VALUE CHAIN ANALYSIS 
          FIGURE 22 PHARMACEUTICAL EXCIPIENTS MARKET TRENDS: VALUE CHAIN ANALYSIS
          FIGURE 23 PHARMACEUTICAL EXCIPIENTS MARKET TRENDS: SUPPLY CHAIN ANALYSIS
    5.6 ECOSYSTEM/MARKET MAP 
          FIGURE 24 PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW: ECOSYSTEM/MARKET MAP
          TABLE 8 SUPPLY CHAIN ECOSYSTEM
    5.7 TECHNOLOGY ANALYSIS 
    5.8 PATENT ANALYSIS 
          FIGURE 25 PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW: PATENT ANALYSIS
           5.8.1 LIST OF MAJOR PATENTS
                    TABLE 9 PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW: MAJOR PATENTS
    5.9 KEY CONFERENCES & EVENTS IN 2023–2024 
          TABLE 10 PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW: DETAILED LIST OF EVENTS AND CONFERENCES
    5.10 TRADE DATA 
           5.10.1 GLYCEROL
                     TABLE 11 HS CODE: 290545 GLYCEROL
           5.10.2 DEXTRINS AND OTHER MODIFIED STARCHES
                     TABLE 12 HS CODE: 350510 DEXTRINS AND OTHER MODIFIED STARCHES (E.G., PREGELATINIZED OR ESTERIFIED STARCHES)
           5.10.3 PROPYLENE GLYCOL
                     TABLE 13 HS CODE: 290532 PROPYLENE GLYCOL (PROPANE-1,2-DIOL)
           5.10.4 CALCIUM CARBONATE
                     TABLE 14 HS CODE: 283650 CALCIUM CARBONATE
           5.10.5 SODIUM CHLORIDE
                     TABLE 15 HS CODE: 250100 SALTS, INCL. TABLE SALT AND DENATURED SALT, AND PURE SODIUM CHLORIDE, WHETHER OR NOT IN AQUEOUS SOLUTION OR CONTAINING ADDED ANTI-CAKING OR FREE-FLOWING AGENTS; SEA WATER
           5.10.6 MANNITOL
                     TABLE 16 HS CODE: 290543 MANNITOL
           5.10.7 CELLULOSE
                     TABLE 17 HS CODE: 3912 CELLULOSE AND ITS CHEMICAL DERIVATIVES, N.E.S., IN PRIMARY FORMS
    5.11 TARIFF AND REGULATORY LANDSCAPE 
           5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
                    5.11.1.1 FDA regulations on pharmaceutical excipients
           5.11.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    5.11.2.1 North America
                                 TABLE 18 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    5.11.2.2 Europe
                                 TABLE 19 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    5.11.2.3 Asia Pacific
                                 TABLE 20 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    5.11.2.4 Latin America
                                 TABLE 21 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    5.11.2.5 Middle East & Africa
                                 TABLE 22 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    5.12 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 23 PHARMACEUTICAL EXCIPIENTS MARKET GROWTH: PORTER’S FIVE FORCES ANALYSIS
           5.12.1 THREAT OF NEW ENTRANTS
           5.12.2 THREAT OF SUBSTITUTES
           5.12.3 BARGAINING POWER OF BUYERS
           5.12.4 BARGAINING POWER OF SUPPLIERS
           5.12.5 DEGREE OF COMPETITION
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 26 INFLUENCE OF COMPANY STAKEHOLDERS IN BUYING PROCESS OF PHARMACEUTICAL EXCIPIENTS
           5.13.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL EXCIPIENTS PRODUCTS AMONG END USERS
                     FIGURE 27 KEY BUYING CRITERIA FOR END USERS
 
6 PHARMACEUTICAL EXCIPIENTS MARKET GROWTH, BY PRODUCT (Page No. - 110)
    6.1 INTRODUCTION 
          TABLE 24 PHARMACEUTICAL EXCIPIENTS MARKET GROWTH, BY PRODUCT, 2021–2028 (USD MILLION)
    6.2 ORGANIC CHEMICALS 
          TABLE 25 PHARMACEUTICAL EXCIPIENTS MARKET GROWTH FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 26 PHARMACEUTICAL EXCIPIENTS MARKET GROWTH FOR ORGANIC CHEMICALS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 27 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET DEMAND FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 28 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET DEMAND FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 29 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET DEMAND FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 30 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET DEMAND FOR ORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.1 OLEOCHEMICALS
                    TABLE 31 OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 32 OLEOCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 33 NORTH AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 34 EUROPE: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 35 ASIA PACIFIC: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 36 LATIN AMERICA: OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.1.1 Fatty alcohols
                               6.2.1.1.1 Wide usage as nonionic surfactants to drive market
                                              TABLE 37 FATTY ALCOHOLS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 38 NORTH AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 39 EUROPE: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 40 ASIA PACIFIC: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 41 LATIN AMERICA: FATTY ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.1.2 Mineral stearates
                               6.2.1.2.1 High adoption of magnesium stearates as excipients in to drive market
                                              TABLE 42 MINERAL STEARATES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 43 NORTH AMERICA: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 44 EUROPE: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 45 ASIA PACIFIC MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 46 LATIN AMERICA: MINERAL STEARATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.1.3 Glycerin
                               6.2.1.3.1 Extensive applications of glycerin to drive market
                                              TABLE 47 GLYCERIN MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 48 NORTH AMERICA: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 49 EUROPE: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 50 ASIA PACIFIC: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 51 LATIN AMERICA: GLYCERIN MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.1.4 Other oleochemicals
                                TABLE 52 OTHER OLEOCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 53 NORTH AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 54 EUROPE: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 55 ASIA PACIFIC: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 56 LATIN AMERICA: OTHER OLEOCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 CARBOHYDRATES
                    TABLE 57 CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 58 CARBOHYDRATES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 59 NORTH AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 60 EUROPE: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 61 ASIA PACIFIC: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 62 LATIN AMERICA: CARBOHYDRATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.1 Sugars
                                TABLE 63 SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 64 SUGARS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 65 NORTH AMERICA: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 66 EUROPE: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 67 ASIA PACIFIC: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 68 LATIN AMERICA: SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.2 Actual sugars
                               6.2.2.2.1 Growing use of actual sugars in pediatric formulations to drive market
                                              TABLE 69 PHARMACEUTICAL EXCIPIENTS MARKET DEMAND, BY ACTUAL SUGARS, 2021–2028 (USD MILLION)
                                              TABLE 70 ACTUAL SUGARS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 71 NORTH AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 72 EUROPE: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 73 ASIA PACIFIC: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 74 LATIN AMERICA: ACTUAL SUGARS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.3 Sugar alcohols
                               6.2.2.3.1 Mannitol to show highest growth in sugar alcohols market
                                              TABLE 75 PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, BY SUGAR ALCOHOLS, 2021–2028 (USD MILLION)
                                              TABLE 76 SUGAR ALCOHOLS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 77 NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 78 EUROPE: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 79 ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 80 LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.4 Artificial sweeteners
                               6.2.2.4.1 Wide usage of aspartame to ensure sustained growth
                                              TABLE 81 ARTIFICIAL SWEETENERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 82 NORTH AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 83 EUROPE: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 84 ASIA PACIFIC: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 85 LATIN AMERICA: ARTIFICIAL SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.5 Cellulose
                                TABLE 86 CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 87 CELLULOSE MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 88 NORTH AMERICA: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 89 EUROPE: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 90 ASIA PACIFIC: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 91 LATIN AMERICA: CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.6 Microcrystalline cellulose
                               6.2.2.6.1 Microcrystalline cellulose to hold largest share
                                              TABLE 92 MICROCRYSTALLINE CELLULOSE MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 93 NORTH AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 94 EUROPE: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 95 ASIA PACIFIC: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 96 LATIN AMERICA: MICROCRYSTALLINE CELLULOSE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.7 Cellulose ethers
                               6.2.2.7.1 Effectiveness in low concentrations to propel usage
                                              TABLE 97 CELLULOSE ETHERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 98 NORTH AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 99 EUROPE: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 100 ASIA PACIFIC: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 101 LATIN AMERICA: CELLULOSE ETHERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.8 CMC & croscarmellose sodium
                               6.2.2.8.1 Advantages to ensure wide usage as suspending agents in injec                                              TABLE preparations
                                              TABLE 102 CMC & CROSCARMELLOSE SODIUM MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 103 NORTH AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 104 EUROPE: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 105 ASIA PACIFIC: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 106 LATIN AMERICA: CMC & CROSCARMELLOSE SODIUM MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.9 Cellulose esters
                               6.2.2.9.1 Wide usage in pharma applications to support market growth
                                              TABLE 107 CELLULOSE ESTERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 108 NORTH AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 109 EUROPE: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 110 ASIA PACIFIC: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 111 LATIN AMERICA: CELLULOSE ESTERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.10 Starch
                                TABLE 112 STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                TABLE 113 STARCH MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 114 NORTH AMERICA: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 115 EUROPE: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 116 ASIA PACIFIC: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 117 LATIN AMERICA: STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.11 Modified starch
                               6.2.2.11.1 Wide use in sustained-release tablets attributed to cold-water swelling and gel barrier formation capabilities
                                              TABLE 118 MODIFIED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 119 NORTH AMERICA: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 120 EUROPE: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 121 ASIA PACIFIC: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 122 LATIN AMERICA: MODIFIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.12 Dried starch
                               6.2.2.12.1 Strong binding and coating properties to favor demand growth
                                              TABLE 123 DRIED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 124 NORTH AMERICA: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 125 EUROPE: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 126 ASIA PACIFIC: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 127 LATIN AMERICA: DRIED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.2.13 Converted starch
                               6.2.2.13.1 Support for enhancing drug solubility and stability to propel adoption
                                              TABLE 128 CONVERTED STARCH MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 129 NORTH AMERICA: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 130 EUROPE: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 131 ASIA PACIFIC: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 132 LATIN AMERICA: CONVERTED STARCH MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 PETROCHEMICALS
                    TABLE 133 PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 134 PETROCHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 135 NORTH AMERICA: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 136 EUROPE: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 137 ASIA PACIFIC: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 138 LATIN AMERICA: PETROCHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.3.1 Glycols
                               6.2.3.1.1 Glycols to hold largest share of petrochemicals segment
                                              TABLE 139 PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, BY GLYCOLS, 2021–2028 (USD MILLION)
                                              TABLE 140 GLYCOLS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 141 NORTH AMERICA: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 142 EUROPE: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 143 ASIA PACIFIC: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 144 LATIN AMERICA: GLYCOLS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.3.2 Povidones
                               6.2.3.2.1 Rising demand for fast-dissolving tablets to propel market growth
                                              TABLE 145 POVIDONES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 146 NORTH AMERICA: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 147 EUROPE: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 148 ASIA PACIFIC: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 149 LATIN AMERICA: POVIDONES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.3.3 Mineral hydrocarbons
                               6.2.3.3.1 Growing preference for topical formulations in pain management to support demand for mineral hydrocarbons
                                              TABLE 150 PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS, BY MINERAL HYDROCARBONS, 2021–2028 (USD MILLION)
                                              TABLE 151 MINERAL HYDROCARBONS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 152 NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 153 EUROPE: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 154 ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 155 LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.3.4 Acrylic polymers
                               6.2.3.4.1 Wide use of acrylic polymers in controlled-release drug formulations to drive market
                                              TABLE 156 ACRYLIC POLYMERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 157 NORTH AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 158 EUROPE: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 159 ASIA PACIFIC: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 160 LATIN AMERICA: ACRYLIC POLYMERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    6.2.3.5 Other petrochemical excipients
                                TABLE 161 OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 162 NORTH AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 163 EUROPE: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 164 ASIA PACIFIC: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 165 LATIN AMERICA: OTHER PETROCHEMICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 PROTEINS
                    6.2.4.1 Growing applications of proteins as carriers for microparticles and nanoparticles to drive market
                                TABLE 166 PROTEINS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 167 NORTH AMERICA: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 168 EUROPE: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 169 ASIA PACIFIC: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 170 LATIN AMERICA: PROTEINS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.5 OTHER ORGANIC CHEMICALS
                    TABLE 171 OTHER ORGANIC CHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 172 NORTH AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 173 EUROPE: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 174 ASIA PACIFIC: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 175 LATIN AMERICA: OTHER ORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 INORGANIC CHEMICALS 
          TABLE 176 PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 177 PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS FOR INORGANIC CHEMICALS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 178 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 179 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 180 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 181 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 CALCIUM PHOSPHATE
                    6.3.1.1 Chemical purity and low incompatibility with drugs to aid usage in pharma applications
                                TABLE 182 CALCIUM PHOSPHATE MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 183 NORTH AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 184 EUROPE: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 185 ASIA PACIFIC: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 186 LATIN AMERICA: CALCIUM PHOSPHATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 METAL OXIDES
                    6.3.2.1 Availability of silicon oxides in hydrophobic, hydrophilic, and granulated forms to aid market growth
                                TABLE 187 METAL OXIDES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 188 NORTH AMERICA: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 189 EUROPE: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 190 ASIA PACIFIC: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 191 LATIN AMERICA: METAL OXIDES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.3 HALITES
                    6.3.3.1 Increased utilization in vaccines and controlled-release formulations to drive demand
                                TABLE 192 HALITES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 193 NORTH AMERICA: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 194 EUROPE: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 195 ASIA PACIFIC: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 196 LATIN AMERICA: HALITES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.4 CALCIUM CARBONATE
                    6.3.4.1 Short disintegration time and excellent mechanical strength for oral formulations to drive market
                                TABLE 197 CALCIUM CARBONATE MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 198 NORTH AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 199 EUROPE: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 200 ASIA PACIFIC: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 201 LATIN AMERICA: CALCIUM CARBONATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.5 CALCIUM SULFATE
                    6.3.5.1 Cost-effectiveness as diluent to support adoption
                                TABLE 202 CALCIUM SULFATE MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 203 NORTH AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 204 EUROPE: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 205 ASIA PACIFIC: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 206 LATIN AMERICA: CALCIUM SULFATE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.6 OTHER INORGANIC CHEMICALS
                    TABLE 207 OTHER INORGANIC CHEMICALS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 208 NORTH AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 209 EUROPE: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 210 ASIA PACIFIC: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 211 LATIN AMERICA: OTHER INORGANIC CHEMICALS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 OTHER CHEMICALS 
          TABLE 212 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 213 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 214 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 215 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 216 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER CHEMICALS, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 PHARMACEUTICAL EXCIPIENTS MARKET PREDICTION, BY FORMULATION (Page No. - 193)
    7.1 INTRODUCTION 
           TABLE 217 PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
    7.2 ORAL FORMULATIONS 
           TABLE 218 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
           TABLE 219 PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION)
           TABLE 220 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
           TABLE 221 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
           TABLE 222 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
           TABLE 223 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.1 TABLETS
                    7.2.1.1 Wide usage to drive market
                                TABLE 224 TYPICAL COMPOSITION OF TABLETS
                                TABLE 225 TABLETS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 226 NORTH AMERICA: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 227 EUROPE: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 228 ASIA PACIFIC: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 229 LATIN AMERICA: TABLETS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.2 CAPSULES
                    TABLE 230 CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 231 CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 232 NORTH AMERICA: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 233 EUROPE: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 234 ASIA PACIFIC: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 235 LATIN AMERICA: CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    7.2.2.1 Hard-gelatin capsules
                               7.2.2.1.1 Ease of manufacturing and versatility to drive market
                                              TABLE 236 HARD-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 237 NORTH AMERICA: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 238 EUROPE: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 239 ASIA PACIFIC: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 240 LATIN AMERICA: HARD-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    7.2.2.2 Soft-gelatin capsules
                               7.2.2.2.1 Stability concerns with highly water-soluble compounds to restrict growth
                                              TABLE 241 SOFT-GELATIN CAPSULES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                              TABLE 242 NORTH AMERICA: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 243 EUROPE: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 244 ASIA PACIFIC: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                              TABLE 245 LATIN AMERICA: SOFT-GELATIN CAPSULES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.3 LIQUID FORMULATIONS
                    7.2.3.1 No dissolution time and rapid absorption to favor adoption
                                TABLE 246 LIQUID FORMULATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                TABLE 247 NORTH AMERICA: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 248 EUROPE: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 249 ASIA PACIFIC: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                                TABLE 250 LATIN AMERICA: LIQUID FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
           7.2.4 OTHER ORAL FORMULATIONS
                    TABLE 251 OTHER ORAL FORMULATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 252 NORTH AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 253 EUROPE: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 254 ASIA PACIFIC: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 255 LATIN AMERICA: OTHER ORAL FORMULATIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 TOPICAL FORMULATIONS 
           7.3.1 ADVANTAGES OF TOPICAL DRUG DELIVERY TO DRIVE MARKET
                    TABLE 256 PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 257 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 258 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 259 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 260 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TOPICAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.4 PARENTERAL FORMULATIONS 
           7.4.1 EMERGENCE OF NEW BIOLOGICAL MOLECULES TO INCREASE DEMAND FOR EXCIPIENTS
                    TABLE 261 TYPICAL COMPOSITION OF PARENTERAL FORMULATIONS
                    TABLE 262 EXCIPIENTS USED IN PARENTERAL FORMULATIONS
                    TABLE 263 PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 264 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 265 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 266 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 267 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR PARENTERAL FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
    7.5 OTHER FORMULATIONS 
          TABLE 268 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 269 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 270 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 271 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 272 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FORMULATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 PHARMACEUTICAL EXCIPIENTS MARKET PREDICTION, BY FUNCTIONALITY (Page No. - 219)
    8.1 INTRODUCTION 
          TABLE 273 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
    8.2 FILLERS & DILUENTS 
           8.2.1 IMPROVED COHESION, DIRECT COMPRESSION, AND FLOW PROPERTIES TO SUPPORT ADOPTION
                    TABLE 274 FILLERS & DILUENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 275 NORTH AMERICA: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 276 EUROPE: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 277 ASIA PACIFIC: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 278 LATIN AMERICA: FILLERS & DILUENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 SUSPENDING & VISCOSITY AGENTS 
           8.3.1 DRUG STABILITY AND TASTE-MASKING ADVANTAGES TO SUPPORT DEMAND
                    TABLE 279 SUSPENDING & VISCOSITY AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 280 NORTH AMERICA: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 281 EUROPE: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 282 ASIA PACIFIC: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 283 LATIN AMERICA: SUSPENDING & VISCOSITY AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 COATING AGENTS 
           8.4.1 INCREASING USE OF SUSTAINED-RELEASE FORMULATIONS IN PHARMA INDUSTRY TO DRIVE MARKET
                    TABLE 284 COATING AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 285 NORTH AMERICA: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 286 EUROPE: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 287 ASIA PACIFIC: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 288 LATIN AMERICA: COATING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 BINDERS 
           8.5.1 FLUIDITY AND COMPRESSIBILITY INTABLET MANUFACTURING TO DRIVE DEMAND
                    TABLE 289 BINDERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 290 NORTH AMERICA: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 291 EUROPE: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 292 ASIA PACIFIC: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 293 LATIN AMERICA: BINDERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.6 FLAVORING AGENTS & SWEETENERS 
           8.6.1 NEED TO IMPROVE DRUG PALATABILITY TO SUPPORT USAGE
                    TABLE 294 FLAVORING AGENTS & SWEETENERS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 295 NORTH AMERICA: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 296 EUROPE: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 297 ASIA PACIFIC: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 298 LATIN AMERICA: FLAVORING AGENTS & SWEETENERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.7 DISINTEGRANTS 
           8.7.1 NEED TO ENSURE RAPID BREAK-UP OF SOLID DOSAGE FORMS TO DRIVE ADOPTION
                    TABLE 299 DISINTEGRANTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 300 NORTH AMERICA: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 301 EUROPE: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 302 ASIA PACIFIC: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 303 LATIN AMERICA: DISINTEGRANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.8 COLORANTS 
           8.8.1 APPLICATIONS IN HARD AND SOFT GELATIN CAPSULES,                     TABLETS, ORAL LIQUIDS, AND TOPICAL CREAMS TO DRIVE MARKET
                    TABLE 304 COLORANTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 305 NORTH AMERICA: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 306 EUROPE: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 307 ASIA PACIFIC: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 308 LATIN AMERICA: COLORANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.9 LUBRICANTS & GLIDANTS 
           8.9.1 NEED TO LESSEN WEAR AND TEAR ON FORMULATIONS TO SUPPORT LUBRICANT USAGE
                    TABLE 309 LUBRICANTS & GLIDANTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 310 NORTH AMERICA: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 311 EUROPE: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 312 ASIA PACIFIC: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 313 LATIN AMERICA: LUBRICANTS & GLIDANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.10 PRESERVATIVES 
           8.10.1 PRESERVATIVES TO SEE SUSTAINED USAGE TO ENSURE LONGER SHELF-LIFE
                     TABLE 314 PRESERVATIVES MARKET, BY REGION, 2021–2028 (USD MILLION)
                     TABLE 315 NORTH AMERICA: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                     TABLE 316 EUROPE: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                     TABLE 317 ASIA PACIFIC: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                     TABLE 318 LATIN AMERICA: PRESERVATIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.11 EMULSIFYING AGENTS 
           8.11.1 HIGH USE OF SOLUBILITY ENHANCEMENT EXCIPIENTS IN LIQUID FORMULATIONS TO DRIVE MARKET
                     TABLE 319 EMULSIFYING AGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
                     TABLE 320 NORTH AMERICA: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                     TABLE 321 EUROPE: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                     TABLE 322 ASIA PACIFIC: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                     TABLE 323 LATIN AMERICA: EMULSIFYING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
    8.12 OTHER FUNCTIONALITIES 
           TABLE 324 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2021–2028 (USD MILLION)
           TABLE 325 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
           TABLE 326 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
           TABLE 327 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
           TABLE 328 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 PHARMACEUTICAL EXCIPIENTS MARKET PREDICTION, BY FUNCTIONALITY APPLICATION (Page No. - 249)
    9.1 INTRODUCTION 
          TABLE 329 PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
    9.2 STABILIZERS 
           9.2.1 IMPROVED DRUG SHELF LIFE AND REDUCED MANUFACTURING DEFECTS TO DRIVE MARKET
                    TABLE 330 PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 331 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 332 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 333 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 334 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR STABILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 TASTE MASKING 
           9.3.1 GREATER PATIENT COMPLIANCE AND ADHERENCE ADVANTAGES TO ENSURE ADOPTION
                    TABLE 335 PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 336 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 337 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 338 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 339 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR TASTE MASKING, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 MODIFIED RELEASE 
           9.4.1 INCREASING USE OF MODIFIED-RELEASE FORMULATIONS TO DRIVE MARKET
                    TABLE 340 PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 341 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 342 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 343 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 344 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR MODIFIED RELEASE, BY COUNTRY, 2021–2028 (USD MILLION)
    9.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT 
           9.5.1 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT EXCIPIENTS ESSENTIAL FOR EFFECTIVE DRUG DELIVERY
                    TABLE 345 PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 346 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 347 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 348 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 349 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR SOLUBILITY & BIOAVAILABILITY, BY COUNTRY, 2021–2028 (USD MILLION)
    9.6 OTHER FUNCTIONALITY APPLICATIONS 
          TABLE 350 PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 351 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 352 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 353 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 354 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR OTHER FUNCTIONALITY APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 PHARMACEUTICAL EXCIPIENTS MARKET PREDICTION, BY REGION (Page No. - 263)
     10.1 INTRODUCTION 
             TABLE 355 PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
     10.2 EUROPE 
             FIGURE 28 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
             10.2.1 EUROPE: RECESSION IMPACT
                        TABLE 356 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 357 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 358 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 359 EUROPE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 360 EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 361 EUROPE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 362 EUROPE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 363 EUROPE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 364 EUROPE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 365 EUROPE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 366 EUROPE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 367 EUROPE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 368 EUROPE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 369 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 370 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 371 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                        TABLE 372 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 373 EUROPE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 374 EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.2.2 GERMANY
                        10.2.2.1 Germany to hold largest market share in Europe
                                      TABLE 375 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 376 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 377 GERMANY: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 378 GERMANY: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 379 GERMANY: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 380 GERMANY: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 381 GERMANY: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 382 GERMANY: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 383 GERMANY: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 384 GERMANY: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 385 GERMANY: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 386 GERMANY: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 387 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 388 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 389 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 390 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 391 GERMANY: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 392 GERMANY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.2.3 UK
                        10.2.3.1 Growing adoption of generics and development of multi-functional, co-processed excipients to drive market
                                      TABLE 393 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 394 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 395 UK: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 396 UK: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 397 UK: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 398 UK: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 399 UK: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 400 UK: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 401 UK: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 402 UK: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 403 UK: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 404 UK: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 405 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 406 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 407 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 408 UK: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 409 UK: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 410 UK: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.2.4 FRANCE
                        10.2.4.1 Large geriatric population to support market growth
                                      TABLE 411 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 412 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 413 FRANCE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 414 FRANCE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 415 FRANCE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 416 FRANCE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 417 FRANCE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 418 FRANCE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 419 FRANCE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 420 FRANCE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 421 FRANCE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 422 FRANCE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 423 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 424 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 425 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 426 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 427 FRANCE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 428 FRANCE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.2.5 ITALY
                        10.2.5.1 Budgetary constraints and restricted healthcare spending to impede growth
                                      TABLE 429 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 430 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 431 ITALY: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 432 ITALY: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 433 ITALY: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 434 ITALY: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 435 ITALY: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 436 ITALY: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 437 ITALY: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 438 ITALY: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 439 ITALY: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 440 ITALY: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 441 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 442 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 443 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 444 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 445 ITALY: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 446 ITALY: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.2.6 SPAIN
                        10.2.6.1 High consumption of biologics to support market growth
                                      TABLE 447 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET PREDICTION, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 448 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 449 SPAIN: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 450 SPAIN: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 451 SPAIN: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 452 SPAIN: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 453 SPAIN: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 454 SPAIN: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 455 SPAIN: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 456 SPAIN: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 457 SPAIN: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 458 SPAIN: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 459 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 460 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 461 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 462 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 463 SPAIN: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 464 SPAIN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.2.7 REST OF EUROPE
                        TABLE 465 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 466 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 467 REST OF EUROPE: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 468 REST OF EUROPE: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 469 REST OF EUROPE: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 470 REST OF EUROPE: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 471 REST OF EUROPE: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 472 REST OF EUROPE: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 473 REST OF EUROPE: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 474 REST OF EUROPE: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 475 REST OF EUROPE: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 476 REST OF EUROPE: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 477 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 478 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 479 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                        TABLE 480 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 481 REST OF EUROPE: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 482 REST OF EUROPE: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
     10.3 NORTH AMERICA 
             10.3.1 NORTH AMERICA: RECESSION IMPACT
                        FIGURE 29 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET SNAPSHOT
                        TABLE 483 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 484 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 485 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 486 NORTH AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 487 NORTH AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 488 NORTH AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 489 NORTH AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 490 NORTH AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 491 NORTH AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 492 NORTH AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 493 NORTH AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 494 NORTH AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 495 NORTH AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 496 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 497 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 498 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                        TABLE 499 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 500 NORTH AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 501 NORTH AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.3.2 US
                        10.3.2.1 US to dominate North American market
                                      TABLE 502 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 503 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 504 US: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 505 US: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 506 US: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 507 US: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 508 US: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 509 US: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 510 US: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 511 US: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 512 US: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 513 US: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 514 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 515 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 516 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 517 US: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 518 US: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 519 US: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.3.3 CANADA
                        10.3.3.1 Strong growth of emerging markets and slowdown in new product approvals to hamper growth
                                      TABLE 520 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 521 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 522 CANADA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 523 CANADA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 524 CANADA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 525 CANADA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 526 CANADA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 527 CANADA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 528 CANADA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 529 CANADA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 530 CANADA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 531 CANADA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 532 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 533 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 534 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 535 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 536 CANADA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 537 CANADA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
     10.4 ASIA PACIFIC 
             10.4.1 ASIA PACIFIC: RECESSION IMPACT
                        TABLE 538 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 539 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 540 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 541 ASIA PACIFIC: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 542 ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 543 ASIA PACIFIC: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 544 ASIA PACIFIC: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 545 ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 546 ASIA PACIFIC: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 547 ASIA PACIFIC: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 548 ASIA PACIFIC: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 549 ASIA PACIFIC: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 550 ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 551 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 552 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 553 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                        TABLE 554 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 555 ASIA PACIFIC: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 556 ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.4.2 CHINA
                        10.4.2.1 Emphasis on generics and off-patent drugs to drive market
                                      TABLE 557 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 558 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 559 CHINA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 560 CHINA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 561 CHINA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 562 CHINA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 563 CHINA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 564 CHINA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 565 CHINA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 566 CHINA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 567 CHINA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 568 CHINA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 569 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 570 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 571 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 572 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 573 CHINA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 574 CHINA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.4.3 JAPAN
                        10.4.3.1 Rapid growth in geriatric population to drive demand for pharmaceuticals
                                      TABLE 575 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 576 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 577 JAPAN: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 578 JAPAN: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 579 JAPAN: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 580 JAPAN: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 581 JAPAN: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 582 JAPAN: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 583 JAPAN: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 584 JAPAN: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 585 JAPAN: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 586 JAPAN: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 587 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 588 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 589 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 590 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 591 JAPAN: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 592 JAPAN: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.4.4 INDIA
                        10.4.4.1 High generics production to support market growth
                                      TABLE 593 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 594 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 595 INDIA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 596 INDIA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 597 INDIA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 598 INDIA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 599 INDIA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 600 INDIA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 601 INDIA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 602 INDIA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 603 INDIA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 604 INDIA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 605 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 606 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 607 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 608 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 609 INDIA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 610 INDIA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.4.5 SOUTH KOREA
                        10.4.5.1 Strong and growing pharma industry to ensure market growth
                                      TABLE 611 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 612 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 613 SOUTH KOREA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 614 SOUTH KOREA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 615 SOUTH KOREA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 616 SOUTH KOREA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 617 SOUTH KOREA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 618 SOUTH KOREA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 619 SOUTH KOREA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 620 SOUTH KOREA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 621 SOUTH KOREA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 622 SOUTH KOREA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 623 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 624 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 625 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 626 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 627 SOUTH KOREA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 628 SOUTH KOREA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.4.6 REST OF ASIA PACIFIC
                        TABLE 629 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 630 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 631 REST OF ASIA PACIFIC: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 632 REST OF ASIA PACIFIC: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 633 REST OF ASIA PACIFIC: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 634 REST OF ASIA PACIFIC: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 635 REST OF ASIA PACIFIC: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 636 REST OF ASIA PACIFIC: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 637 REST OF ASIA PACIFIC: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 638 REST OF ASIA PACIFIC: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 639 REST OF ASIA PACIFIC: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 640 REST OF ASIA PACIFIC: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 641 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 642 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 643 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                        TABLE 644 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 645 REST OF ASIA PACIFIC: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 646 REST OF ASIA PACIFIC: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
     10.5 LATIN AMERICA 
             10.5.1 GROWING GERIATRIC POPULATION AND DISEASE PREVALENCE TO DRIVE MARKET
             10.5.2 LATIN AMERICA: RECESSION IMPACT
                        TABLE 647 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 648 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 649 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 650 LATIN AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 651 LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 652 LATIN AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 653 LATIN AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 654 LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 655 LATIN AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 656 LATIN AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 657 LATIN AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 658 LATIN AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 659 LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 660 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 661 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 662 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                        TABLE 663 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 664 LATIN AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 665 LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.5.3 BRAZIL
                        10.5.3.1 Brazil to hold largest share in LATAM market
                        TABLE 666 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 667 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 668 BRAZIL: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 669 BRAZIL: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 670 BRAZIL: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 671 BRAZIL: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 672 BRAZIL: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 673 BRAZIL: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 674 BRAZIL: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 675 BRAZIL: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 676 BRAZIL: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 677 BRAZIL: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 678 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 679 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 680 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                        TABLE 681 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 682 BRAZIL: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 683 BRAZIL: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.5.4 REST OF LATIN AMERICA
                        TABLE 684 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                        TABLE 685 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 686 REST OF LATIN AMERICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 687 REST OF LATIN AMERICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 688 REST OF LATIN AMERICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 689 REST OF LATIN AMERICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 690 REST OF LATIN AMERICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 691 REST OF LATIN AMERICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 692 REST OF LATIN AMERICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 693 REST OF LATIN AMERICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 694 REST OF LATIN AMERICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 695 REST OF LATIN AMERICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 696 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 697 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 698 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                        TABLE 699 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 700 REST OF LATIN AMERICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 701 REST OF LATIN AMERICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
     10.6 MIDDLE EAST & AFRICA 
             10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
             10.6.2 MIDDLE EAST
                        10.6.2.1 Growing attention from global players to favor growth of middle eastern markets
                                      TABLE 702 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 703 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 704 MIDDLE EAST: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 705 MIDDLE EAST: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 706 MIDDLE EAST: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 707 MIDDLE EAST: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 708 MIDDLE EAST: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 709 MIDDLE EAST: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 710 MIDDLE EAST: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 711 MIDDLE EAST: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 712 MIDDLE EAST: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 713 MIDDLE EAST: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 714 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 715 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 716 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 717 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 718 MIDDLE EAST: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 719 MIDDLE EAST: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
             10.6.3 AFRICA
                        10.6.3.1 Rising urbanization, growing healthcare access to offer growth opportunities
                                      TABLE 720 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
                                      TABLE 721 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 722 AFRICA: OLEOCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 723 AFRICA: CARBOHYDRATES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 724 AFRICA: SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 725 AFRICA: ACTUAL SUGARS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 726 AFRICA: SUGAR ALCOHOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 727 AFRICA: CELLULOSE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 728 AFRICA: STARCH MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 729 AFRICA: PETROCHEMICALS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 730 AFRICA: GLYCOLS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 731 AFRICA: MINERAL HYDROCARBONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 732 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR INORGANIC CHEMICALS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 733 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 734 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2021–2028 (USD MILLION)
                                      TABLE 735 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET FOR ORAL FORMULATIONS, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 736 AFRICA: CAPSULES MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 737 AFRICA: PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2021–2028 (USD MILLION)
 
11 COMPETITIVE LANDSCAPE (Page No. - 415)
     11.1 INTRODUCTION 
     11.2 KEY PLAYER STRATEGIES/RIGHT-TO-WIN 
             FIGURE 30 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS
     11.3 REVENUE SHARE ANALYSIS 
             FIGURE 31 REVENUE ANALYSIS OF KEY PLAYERS (2020–2022)
     11.4 MARKET SHARE ANALYSIS 
             FIGURE 32 PHARMACEUTICAL EXCIPIENTS MARKET: MARKET SHARE ANALYSIS (2022)
             TABLE 738 PHARMACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION
     11.5 COMPANY EVALUATION MATRIX 
             11.5.1 STARS
             11.5.2 EMERGING LEADERS
             11.5.3 PERVASIVE PLAYERS
             11.5.4 PARTICIPANTS
                        FIGURE 33 PHARMACEUTICAL EXCIPIENTS MARKET: COMPANY EVALUATION MATRIX, 2022
             11.5.5 COMPANY FOOTPRINT
                        TABLE 739 PRODUCT FOOTPRINT (25 COMPANIES)
                        TABLE 740 REGIONAL FOOTPRINT (25 COMPANIES)
     11.6 START-UP/SME EVALUATION MATRIX 
             11.6.1 PROGRESSIVE COMPANIES
             11.6.2 STARTING BLOCKS
             11.6.3 RESPONSIVE COMPANIES
             11.6.4 DYNAMIC COMPANIES
                        FIGURE 34 PHARMACEUTICAL EXCIPIENTS MARKET: START-UP/SME MATRIX, 2022
             11.6.5 COMPETITIVE BENCHMARKING
                        TABLE 741 PHARMACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
                        TABLE 742 PHARMACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
     11.7 COMPETITIVE SCENARIO AND TRENDS 
             11.7.1 PRODUCT LAUNCHES
                        TABLE 743 PHARMACEUTICAL EXCIPIENTS MARKET: PRODUCT LAUNCHES, JANUARY 2020 TO DECEMBER 2023
             11.7.2 DEALS
                        TABLE 744 PHARMACEUTICAL EXCIPIENTS MARKET: DEALS, JANUARY 2020 TO DECEMBER 2023
             11.7.3 OTHER DEVELOPMENTS
                        TABLE 745 PHARMACEUTICAL EXCIPIENTS MARKET: OTHER DEVELOPMENTS, JANUARY 2020 TO DECEMBER 2023
 
12 COMPANY PROFILES (Page No. - 429)
(Business overview, Products/Solutions/Services offered, Recent developments & MnM Vie
     12.1 KEY PLAYERS 
             12.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC.
                        TABLE 746 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW
                        FIGURE 35 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT (2022)
             12.1.2 BASF SE
                        TABLE 747 BASF SE: BUSINESS OVERVIEW
                        FIGURE 36 BASF SE: COMPANY SNAPSHOT (2022)
             12.1.3 ASHLAND INC.
                        TABLE 748 ASHLAND INC.: BUSINESS OVERVIEW
                        FIGURE 37 ASHLAND INC.: COMPANY SNAPSHOT (2022)
             12.1.4 EVONIK INDUSTRIES AG
                        TABLE 749 EVONIK INDUSTRIES AG: BUSINESS OVERVIEW
                        FIGURE 38 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT (2022)
             12.1.5 KERRY GROUP PLC
                        TABLE 750 KERRY GROUP PLC: BUSINESS OVERVIEW
                        FIGURE 39 KERRY GROUP PLC: COMPANY SNAPSHOT (2022)
             12.1.6 ROQUETTE FRÈRES
                        TABLE 751 ROQUETTE FRÈRES: BUSINESS OVERVIEW
             12.1.7 MERCK KGAA
                        TABLE 752 MERCK KGAA: BUSINESS OVERVIEW
                        FIGURE 40 MERCK KGAA: COMPANY SNAPSHOT (2022)
             12.1.8 ASSOCIATED BRITISH FOODS PLC
                        TABLE 753 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
                        FIGURE 41 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT (2022)
             12.1.9 ADM
                        TABLE 754 ADM: BUSINESS OVERVIEW
                        FIGURE 42 ADM: COMPANY SNAPSHOT (2022)
             12.1.10 WACKER CHEMIE AG
                        TABLE 755 WACKER CHEMIE AG: BUSINESS OVERVIEW
                        FIGURE 43 WACKER CHEMIE AG: COMPANY SNAPSHOT (2022)
             12.1.11 AIR LIQUIDE
                        TABLE 756 AIR LIQUIDE: BUSINESS OVERVIEW
                        FIGURE 44 AIR LIQUIDE: COMPANY SNAPSHOT (2022)
             12.1.12 DOW
                        TABLE 757 DOW: BUSINESS OVERVIEW
                        FIGURE 45 DOW: COMPANY SNAPSHOT (2022)
             12.1.13 LUBRIZOL CORPORATION (BERKSHIRE HATHAWAY)
                        TABLE 758 LUBRIZOL CORPORATION: BUSINESS OVERVIEW
             12.1.14 COLORCON
                        TABLE 759 COLORCON: BUSINESS OVERVIEW
             12.1.15 DFE PHARMA
                        TABLE 760 DFE PHARMA: BUSINESS OVERVIEW
*Details on Business overview, Products/Solutions/Services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
     12.2 OTHER PLAYERS 
             12.2.1 INNOPHOS
             12.2.2 J. RETTENMAIER & SÖHNE GMBH + CO KG
             12.2.3 ACTYLIS
             12.2.4 MEGGLE GMBH & CO. KG
             12.2.5 FUJI CHEMICAL INDUSTRIES CO., LTD.
             12.2.6 COREL PHARMA CHEM
             12.2.7 BIOGRUND GMBH
             12.2.8 NITIKA PHARMACEUTICAL SPECIALTIES PVT. LTD.
             12.2.9 R.T. VANDERBILT HOLDING COMPANY, INC.
             12.2.10 BENEO
 
13 APPENDIX (Page No. - 496)
     13.1 DISCUSSION GUIDE 
     13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     13.3 CUSTOMIZATION OPTIONS 
     13.4 RELATED REPORTS 
     13.5 AUTHOR DETAILS 

This study involved four major activities in estimating the current size of the pharmaceutical excipients market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. These findings, assumptions, and sizing were then validated with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size (pharmaceutical excipients market size). After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive technical, market-oriented, and commercial study of the pharmaceutical excipients market. The secondary sources used for this study include the European Federation of Pharmaceutical Industries and Associations (EFPIA), Pharmaceutical Research and Manufacturers of America (PhRMA), Parenteral Drug Association (PDA), International Pharmaceutical Excipients Council (IPEC), International Journal of Production Research (IJPR), Generics and Biosimilars Initiative (GaBI), PharmaTimes, World Journal of Pharmaceutical Sciences, International Federation of Pharmaceutical Manufacturers & Association (IFPMA), Annual Reports, SEC Filings, Investor Presentations, Expert Interviews, and MarketsandMarkets Analysis. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives. Secondary data was collected and analyzed to arrive at the overall size of the global pharmaceutical excipients market, which was validated through primary research.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Pharmaceutical Excipients Market Size, and Share

Note: Tiers are defined based on a company’s total revenue. As of 2022, Tier 1 = >USD 1 Bn, Tier 2 = USD 500 Mn to USD 1 Bn, and Tier 3 <USD 500 Mn.

To know about the assumptions considered for the study, download the pdf brochure

Pharmaceutical Excipients Market Size Estimation

The global size of the pharmaceutical excipients market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size (pharmaceutical excipients market size) includes the following:

  • The major players in the industry and market have been identified through extensive primary and secondary research.
  • The revenues generated from the pharmaceutical excipients business of players operating in the market have been determined through secondary research and primary analysis.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Pharmaceutical Excipients Market Size Estimation Methodology-Bottom-up approach

Pharmaceutical Excipients Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach-

Pharmaceutical Excipients Market Size, and Share

Data Triangulation

After estimating the overall market size (pharmaceutical excipients market size) from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Pharmaceutical excipients are inactive substances added to medications alongside the active pharmaceutical ingredient (API). They serve various purposes, such as improving the drug's stability, bioavailability, delivery, and overall effectiveness. These components, including preservatives, binders, fillers, disintegrants, lubricants, and flavoring agents, contribute to the final drug product's quality and efficacy.

Key Stakeholders

  • Manufacturers, importers & exporters, traders, distributors, and suppliers of pharmaceutical excipients
  • Pharmaceutical and biopharmaceutical companies
  • Distributors and suppliers of pharmaceutical excipients
  • Contract manufacturing organizations (CMOs)
  • Suppliers and distributors of pharmaceutical products
  • Research and development (R&D) companies
  • Pharmaceutical/medical associations
  • Regulatory bodies & government agencies
  • Research institutes and government organizations
  • Venture capitalists and investors
  • Business research and consulting service providers
  • Market research and consulting firms

The main objectives of this study are as follows:

  • To define, describe, and forecast the pharmaceutical excipients market based on product, functionality, formulation, functionality applicatons and region.
  • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall antibody drug conjugate market.
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to six regions, namely: North America, Europe, the Asia Pacific (APAC), Latin America (LATAM), the Middle East  and Africa
  • To profile the key players and analyze their market shares and core competencies2
  • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, expansions, and strategic alliances
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Country-wise Information:

  • Analysis for additional countries (up to five)

Company Information:

  • Detailed analysis and profiling of additional market players (up to five)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
PH 3047
Published ON
Nov, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Pharmaceutical Excipients Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback